Astellas, Seagen and Merck announce FDA acceptance of sBLA for PADCEV for urothelial cancer
This combination has the potential to be the first treatment option combining an antibody-drug conjugate plus an immunotherapy in this treatment setting
This combination has the potential to be the first treatment option combining an antibody-drug conjugate plus an immunotherapy in this treatment setting
The advanced laboratory spread over 2,200 Square feet has multiple laboratory divisions including Hematology, Biochemistry, Clinical pathology, Serology and Microbiology
The newly built centre will work as the state-of-the-art facility for not just ethical animal studies but spans from basic, applied to regulatory animal research.
Her previous role at Novartis, where she was general manager, data & digital, in global drug development, also included accountability for driving the DCT strategy, programs and platforms
This is a phase two randomized, double-blind, parallel-group, placebo and active-controlled study
The company will submit an action plan on the observations and will engage with US FDA for next steps.
The investment will enable the company to enter European markets as well as enhance margins in current markets
He has global experience in strategic and operational leadership including at Board, CEO and Senior Corporate levels
The yoga protocol included gentle and restorative yoga postures(asana) with regular periods of relaxation and pranayama
Silodosin capsules treat signs and symptoms of an enlarged prostate gland
Subscribe To Our Newsletter & Stay Updated